FRS
0.026
160%
OCT
0.045
-42.3%
CRS
0.062
138.5%
NRZ
0.002
-33.3%
AVE
0.007
133.3%
CHM
0.006
-25%
LAT
0.074
111.4%
JAV
0.003
-25%
RLL
0.004
100%
HYD
0.019
-24%
SCN
0.027
80%
DUN
0.033
-23.3%
BP8
0.005
66.7%
TFL
0.01
-23.1%
EVR
0.005
66.7%
EXR
0.034
-22.7%
RGL
0.005
66.7%
GLL
0.007
-22.2%
SLM
0.105
66.7%
OZM
0.125
-21.9%
RR1
0.013
62.5%
TMG
0.036
-21.7%
RAS
0.025
56.3%
AGH
0.02
-20%
BGE
0.03
50%
CRR
0.004
-20%
CDT
0.003
50%
EM2
0.008
-20%
TMK
0.003
50%
CVL
1.06
-19.4%
BSX
0.051
45.7%
NWM
0.013
-18.8%
VIT
0.112
41.8%
AQD
0.04
-18.4%
CMO
0.024
41.2%
BUS
0.155
-18.4%
TOR
0.1
40.8%
LOT
0.195
-17%
EXT
0.018
38.5%
PUA
0.01
-16.7%

PTR, NYM, MX1, BM8, TEE, BVS, SS1, IMU & VR1

What’s Hot, Not & Doing
Brought to you by TSN Contributor & Wealth Advisor Nick Kelso

What’s Hot – PTR, NYM, MX1, BM8, TEE, BVS, SS1, IMU & VR1
What’s Not – CYB

What’s Hot
PTRPetratherm Limited today closed up 90% to finish at 38c on $10m stock traded. The reason they were up today was because they announced maiden drill results from the Rosewood Prospect within its Muckanippie Project located in South Australia.

Assay results from the first 5 step out drill holes over a 2km trend have intersected up to 22m @ 19.1% HM (heavy minerals) from 8m including 1m @ 39.7% HM.

The initial small batch was fast tracked to confirm nature of mineralisation and to ensure HM could be recovered using standard heavy liquid separation (HLS) methods.

NYMNarryer Metals Limited today closed up 58% to finish at 5.7c on $430k stock traded. The reason they were up today was because they reiterated Petratherm’s announcement which you would have read about above.

Narryer currently has a joint venture with PTR on a tenement (EL 6715) located adjacent to Petratherm’s Rosewood HM prospect.

Drilling has been completed at EL 6715 and they are currently awaiting assay results from 11 drill holes.

Roughly a fortnight ago, NYM announced assay results from its Rocky Gully project located in the Great Southern region of WA.

MX1 – Micro-X Limited today closed up 38% to finish at 9.8c on $460k stock traded. The reason they were up today was because they announced the award of a US$8.2m (A$12.5m) contract with the US Advanced Research Projects Agency for Health (ARPA-H) to develop a first prototype CT scanner over a 2-year program.

There is also the potential for a further US$8.2m (A$12.5m) contract to develop Portable Full Body CT through to FDA 510(k) submission over an additional 3 years, subject to an ARPA-H option.

Yesterday, MX1 released a response to a publication on a US Government Agency website which stated that it was awarded the development contract above.

BM8Battery Age Minerals Limited today closed up 35% to finish at 13.5c on $360k stock traded. There was no news out today but last week they announced an exploration and strategy update for its Bleiberg Germanium Project located in Austria.

BM8 has placed greater emphasis on Bleiberg which is driven by the increasing demand for critical minerals, particularly germanium.

Last night, China announced a ban on exports of gallium, germanium and antimony to the US a day after the Biden administration imposed expanded restrictions on the sale of advanced US technology to China.

 

TEETop End Energy Limited today closed up 30% to finish at 13c on $320k stock traded. The reason they were up today was because they announced the acquisition of the Serpentine Natural Hydrogen Project located in Kansas, USA.

The project is strategically located in the heart of an active land rush, fueled by historical observations of natural hydrogen and a surge in recent exploration activity.

As a result of the acquisition, TEE has announced a placement to raise $6m @ 10c through the boys and girls at Inyati Capital.

BVSBravura Solutions Limited today closed up 21% to finish at $2 on $9m stock traded. The reason they were up today was because they announced an upgraded FY25 guidance and dividend update.

Bravura now expects FY25 cash EBITDA to be in the range of $33m-$36m (previously $28m- $32m) and revenue to be in the range of $240m-$245m (previously $235m-$240m).

The upgraded FY25 guidance follows the successful transformation and execution of the business strategy over the past 18 months.

As a result of the company’s return to profitability and cash generation, Bravura intends to recommence the declaration of dividends in February.

SS1Sun Silver Limited today closed up 16% to finish at 87c on $2.2m stock traded. There was no news out today but yesterday they announced assay results from its Maverick Springs Silver-Gold Project located in Nevada, USA.

Drilling returning grades of 4.57m @ 1,249g/t AgEq from 193.55m & 3.24m @ above 10,000ppm Sb 195.07m.

The antimony grades were above the upper limit of detection and re-assaying is in progress to determine the mineralised concentration.

IMUImugene Limited today closed up 11% to finish at 4.2c on $2.3m stock traded. There was no news out today but last month they announced the first patient had been dosed in the intratumoural (IT) combination arm of its Phase 1 onCARlytics (CF33-CD19) clinical trial.

This development is part of the OASIS trial, which is designed to assess the safety and efficacy of its CD19 oncolytic virotherapy in patients with advanced or metastatic solid tumours.

The OASIS trial explores two routes of administration, intratumoural (IT) injection and intravenous (IV) infusion.

VR1Vection Technologies Limited today closed up 10% to finish at 2.3c on $400k stock traded. The reason they were up today was because they announced a $0.5m contract cybersecurity-focused ICT endpoints contract was awarded in the defence sector.

The contract is with a technology service provider that specialises in cybersecurity and infrastructure security solutions for law enforcement, government agencies, and security agencies.

This is a repeat order from a customer which awarded a contract valued at $2.1m back in May and confirms their successful collaboration.

What’s Not 
CYBAucyber Limited today closed down 35% to finish at 13c on $170k stock traded. The reason they were down today was because they released a trading update which revealed an underlying EBITDA loss of $1.3m for the four months to October 31st.

Unaudited revenues are approximately 29% below its FY25 budget, CYB does not expect to meet its FY25 guidance for revenue of $36.6m and as a result has withdrawn FY25 guidance.

Revenues in the Cyber Security, Cloud Solutions and Managed Services businesses have all fallen short of expectations, principally due to slower than expected new customer uptake during the period of integration.

 

Rats Rant – IMPORTANT INFORMATION
The idea of this report is to be informative and hopefully point out some stocks that you wouldn’t ordinarily have seen during the day, maybe even have a laugh too.This report IS NOT personal advice. Sanlam Private Wealth Pty Ltd DOES NOT PROVIDE personal advice, Sanlam Private Wealth provides General Financial Product Advice.All advice included in The Rat’s Rant is General Advice. Please refer to the General Advice Warning. The views expressed in this report are my views and may not necessarily reflect the same views as Sanlam Private Wealth.It is very important to refer to the ASX website for information on any companies / stock that are contained in this report and as always please consult your financial adviser before acting.

Important Notice
Rat Consulting Pty Ltd (ABN 81 148 181 588 ) Authorised Representative (No 001281456) of Sanlam Private Wealth Ltd (ABN 18 136 960 775) holder of Australian Financial Services Licence (AFSL 337 927).